Figure 2.
Cumulative incidence of proven or probable invasive fungal infections according to antifungal prophylaxis. The probability of infection among all patients is shown. The number of patients at risk (alive) at each interval in the fluconazole (flu) arm and itraconazole (itra) arm is indicated. The P value shown was calculated from tests comparing the incidences at 6 months.